Guanfacine Extended-Release (guanfacine) NDC 60429-962

Product information

Brand name (proprietary)

Guanfacine Extended-ReleaseSuffix: Extended-Release

Generic name (nonproprietary)

guanfacine

Active ingredients

Guanfacine — 3 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Golden State Medical Supply, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 201408

Marketing start

Jun 2, 2015

Marketing end

Apr 30, 2027

Other FDA classes

Adrenergic alpha2-Agonists (Mechanism)

Identifiers

Product ID 60429-962_52d4ad1f-7382-4944-e063-6294a90a004bSPL ID 52d4ad1f-7382-4944-e063-6294a90a004bSPL set ID 6006df06-0448-462d-b81e-7add50a6d71bRxCUI 862006, 862013, 862019, 862025UNII 30OMY4G3MK

Pharmacologic class

Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460429096201 followed by a unit qualifier and the quantity Copy

Package 60429-0962-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 201408

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.